Embryonic or fetal antigens (EAs) are expressed on developing rodent fetus (mouse, hamster, rat, guinea pig) and on human fetus. EAs on the embryo cells arouse cellular and humoral immune responses in their syngeneically pregnant mothers which have been partially characterized. Antigens cross-reactive with EAs have been detected on every major histologic class of rodent and human tumor. These reexpressed EAs or fetal gene products on tumors are termed oncofetal antigens (OFAs). Little is known about the expression or regulation of the immune responses to ionizing radiation promoted neoplasia or the effects of radiation on immune responses to OFAs. The specific goals of the proposed study are to confirm the presence of specific OFAs on radiation-induced primary tumors of mice using unique monoclonal antibodies prepared against phasespecific mouse embryonic antigens by immunization with syngeneic fetus. The EA epitopes reactive with these selected monoclonal antibodies have been partially characterized. Then, the time course of OFA expression in radiation promoted neoplasia would be assessed in vitro and in vivo. The irradiated host's immunoregulatory responses to specific OFAs will be carefully catalogued. The effects of acute whole body irradiation on the specific immune response potential to OFA expression on primary and passaged radiation-induced tumors would be determined from these studies. The objectives of the project are to determine (1) if specific OFA expression is a fundamental trait of radiation-induced tumors in mice and (2) whether radiation-induced damage of the immune response contributes to lymphoma or sarcoma development. We will determine if activation of c onc-gene expression parallels OFA expression and if c-onc or v-onc gene encoded products and OFAs are interrelated.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Radiation Study Section (RAD)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of South Alabama
Schools of Medicine
United States
Zip Code
Coggin Jr, J H; Barsoum, A L; Rohrer, J W (1999) 37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers. Anticancer Res 19:5535-42
Coggin Jr, J H; Rohrer, J W; Barsoum, A L (1997) A new immunobiological view of radiation-promoted lymphomagenesis. Int J Radiat Biol 71:81-94
Rohrer, J W; Coggin Jr, J H (1995) CD8 T cell clones inhibit antitumor T cell function by secreting IL-10. J Immunol 155:5719-27
Rohrer, J W; Culpepper, C; Barsoum, A L et al. (1995) Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning. J Immunol 154:2266-80
Rashid, H U; Barsoum, A L; Cao, T M et al. (1994) Identification of partial complementary DNA clones encoding a 59-kd protein with characteristics of a unique oncofetal antigen. J Natl Cancer Inst 86:515-26
Rohrer, J W; Rohrer, S D; Barsoum, A et al. (1994) Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells. J Immunol 152:754-64
Barsoum, A L; Coggin Jr, J H (1993) Purification and partial characterization of 200 kDa oncofetal antigen from radiation induced murine lymphocytic lymphoma. Int J Biochem 25:483-9
Rohrer, S D; Sarli, R N; Barsoum, A L et al. (1992) Expression of 44-kilodalton oncofetal antigen as a premalignancy marker in X irradiation-induced murine T-cell lymphoma. J Natl Cancer Inst 84:602-9
Barsoum, A L; Coggin Jr, J H (1991) Isolation and partial characterization of a soluble oncofetal antigen from murine and human amniotic fluids. Int J Cancer 48:248-52
Hester, R B; Rohrer, S D; Liu, P I et al. (1990) Differential expression of class I major histocompatibility complex determinants by lymphoblastic leukemia-lymphoma cell lines. J Natl Cancer Inst 82:1209-14

Showing the most recent 10 out of 14 publications